Is GHRP-6 legal in the United States?

FDA COMPOUNDING LIST (503A)

GHRP-6 is in category 2 of FDA's 503A list of bulk substances that may present significant safety risks in compounding, since 2023-09-29.

Compounded drugs containing GHRP-6 may pose risk for immunogenicity for certain routes of administration due to the potential for aggregation and peptide-related impurities. FDA has identified limited safety-related information, but the available data reveal safety concerns including potential effect on cortisol and increase in blood glucose due to decreases in insulin sensitivity.

Regulator FDA list, read 2026-10-03. Not legal advice.

GHRP-6 in every country read: legal status by country. All peptides: are peptides legal?